R. K. Sahay, “Personalized Care with DPP4i/SGLT2i Strategy as Initial-Line in the Management of Type 2 Diabetes Mellitus with Cardiovascular Risk: DELPHI Statement”, ccm, vol. 8, no. 2, pp. 111–117, Mar. 2024.